1. Home
  2. LXFR vs PRTA Comparison

LXFR vs PRTA Comparison

Compare LXFR & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$13.33

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$8.68

Market Cap

482.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
PRTA
Founded
1898
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.4M
482.3M
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
LXFR
PRTA
Price
$13.33
$8.68
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$19.00
AVG Volume (30 Days)
118.1K
361.4K
Earning Date
01-01-0001
05-20-2026
Dividend Yield
4.01%
N/A
EPS Growth
N/A
17.75
EPS
0.28
N/A
Revenue
$384,600,000.00
$814,000.00
Revenue This Year
$0.65
$1,395.77
Revenue Next Year
N/A
N/A
P/E Ratio
$46.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$4.32
52 Week High
$16.03
$16.16

Technical Indicators

Market Signals
Indicator
LXFR
PRTA
Relative Strength Index (RSI) 33.20 40.49
Support Level $12.29 $8.10
Resistance Level $13.62 $8.78
Average True Range (ATR) 0.57 0.49
MACD -0.29 0.01
Stochastic Oscillator 19.36 34.41

Price Performance

Historical Comparison
LXFR
PRTA

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: